1. Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer
   Sai Kiran S.S. Pindiprolu et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
2. Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinomaviaWnt/β-catenin signaling pathway
   ZhongYu Jiang et al, 2019, RSC Advances CrossRef
3. Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer
   Huimin Liu et al, 2020, Pharmacological Research CrossRef